Summit Financial Group, Inc. Becton Dickinson & CO Transaction History

Summit Financial Group, Inc.

$279 Million
Q1 2024

A detailed history of Summit Financial Group, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Summit Financial Group, Inc. holds 1,012 shares of BDX stock, worth $228,155. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,012

Previous 1,017 0.49%

Holding current value

$228,155

Previous $247,000 1.21%

% of portfolio

0.09%

Previous 0.1%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$233.45 - $247.73 $1,167 - $1,238	-5 Reduced 0.49%	1,012 $250,000
Q4 2023 Jan 12, 2024	BUY	$232.24 - $267.23 $1,161 - $1,336	5 Added 0.49%	1,017 $247,000
Q2 2023 Jul 13, 2023	SELL	$238.39 - $265.32 $27,414 - $30,511	-115 Reduced 10.2%	1,012 $267,000
Q4 2021 Jan 10, 2022	SELL	$230.08 - $250.94 $46,936 - $51,191	-204 Reduced 15.33%	1,127 $284,000
Q3 2021 Oct 08, 2021	SELL	$232.72 - $256.47 $14,195 - $15,644	-61 Reduced 4.38%	1,331 $327,000
Q2 2021 Jul 06, 2021	BUY	$232.65 - $254.58 $108,647 - $118,888	467 Added 50.49%	1,392 $339,000
Q1 2021 Apr 07, 2021	SELL	$232.09 - $256.88 $3,481 - $3,853	-15 Reduced 1.6%	925 $225,000
Q4 2020 Jan 07, 2021	SELL	$221.92 - $245.94 $19,085 - $21,150	-86 Reduced 8.38%	940 $235,000
Q2 2020 Jul 06, 2020	SELL	$219.9 - $263.41 $439 - $526	-2 Reduced 0.19%	1,026 $245,000
Q3 2019 Oct 09, 2019	BUY	$230.58 - $256.08 $46,577 - $51,728	202 Added 24.46%	1,028 $260,000
Q2 2019 Jul 03, 2019	BUY	$217.4 - $246.08 $179,572 - $203,262	826 New	826 $208,000

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Group, Inc. with notifications on news.

Account

Summit Financial Group, Inc. Becton Dickinson & CO Transaction History